FDA is encouraging testosterone sponsors to work together on a single clinical trial to address whether the drugs cause an increased risk of heart attack or stroke; however, sponsors may elect to work on the new post-marketing requirement alone.
Testosterone Products Need Post-Market Cardiovascular Trial
Labeling updates will also clarify approved uses and warn of possible increased risk of heart attack and stroke; impact on products in development unclear.